Study Findings from Huazhong University of Science and Technology Broaden Understanding of Encephalitis (Case report: Ofatumumab treatment in anti-DPPX autoimmune encephalitis).

Předmět:	ANTI-NMDA receptor encephalitis CENTRAL nervous system viral diseases ENCEPHALITIS CENTRAL nervous system infections CENTRAL nervous system diseases
Zdroj:	Immunotherapy Weekly; 7/16/2024, p2586-2586, 1p
Abstrakt:	A case report from Huazhong University of Science and Technology in China discusses the treatment of anti-DPPX autoimmune encephalitis with ofatumumab. DPPX antibody encephalitis is a rare autoimmune condition that presents with severe neuropsychiatric symptoms. The patient in this case had an insidious onset and was unresponsive to standard immunotherapies, leading to a switch to ofatumumab. After five doses of the medication and 12 months of follow-up, the patient showed improvement with only mild cognitive deficits. This research provides valuable insights into the diagnosis and treatment of this challenging condition. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu